Roche: European Commission Grants Marketing Authorisation Fo

Roche (RHHBY) announced the European Commission has granted marketing authorisation for Tecentriq SC, a PD-L1 cancer immunotherapy for subcutaneous injection. The authorisation applies to all approved indications of Tecentriq IV.

Related Keywords

Massachusetts , United States , , Citigroup Inc , Fedex Corp , Bay Inc , Roche , Ecentriq Sc ,